Olivier Theodoly presented the results of the IMMUNOCHIP project, selected for funding through the 2024 Cancéropôle Maturation call. The project sought to demonstrate the technological feasibility of novel diagnostic microdevices designed to guide cancer immunotherapy through the functional profiling of immune cells. Prototype tests were developed and evaluated to assess the activation and functional responses of T cells, CAR-T cells and NK cells.
https://canceropole-paca.com/agenda/seminaire-annuel-2023-du-canceropole-provence-alpes-cote-dazur/
You must be logged in to post a comment.